ARHGEF16 and colorectal carcinoma: In CRC, independent of this pathway, after interacting with phosphorylated (S897) ephrin type-A receptor 2, Ephexin4 activates RhoG/PI3K signaling thereby enhancing cell migration and resistance to anoikis (Figure 1) (Kawai et al., 2013).